Stereotaxis STXS
NYSE STXS
$0.83 -0.02 (-2.35%)
At close: Nov 13, 2026 · 4:00 PM EST

Stereotaxis (STXS) Non-Current Deferred Tax Liability (2021 - 2023)

Updated

Stereotaxis' Non-Current Deferred Tax Liability came in at $1.23 million for Q4 2023, down 4.6% from $1.29 million a year earlier.

Analysis

Stereotaxis (STXS) Non-Current Deferred Tax Liability (2021 - 2023) Analysis & Trends

  • Going back by year, Non-Current Deferred Tax Liability was $1.29 million in FY2022 (-6.8%) and $1.39 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Stereotaxis 83.17 Mn 83.17 Mn 3.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.23 Mn
Dec 31, 2022 1.29 Mn
Dec 31, 2021 1.39 Mn
API Access

Stereotaxis Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=STXS&period=max&api_key=YOUR_API_KEY